Soy extract could slow Alzheimer's progression, new study hints
NCT ID NCT07385937
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a natural compound from soy, called genistein, can slow down memory and thinking problems in people with mild cognitive impairment (MCI), often an early sign of Alzheimer's disease. About 150 adults over 50 with MCI will take either genistein or a placebo daily for 18 months. Researchers will track changes in cognitive function and daily living skills to see if the supplement helps preserve brain health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCAM HiTech, Sport & Health Innovation Hub
Murcia, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new PET tracer light up Alzheimer's plaques in the living brain?
- Could Brain-Boosting exercises help older adults stay steady on their feet?
- Brain scans could unlock the hidden timeline of Alzheimer's
- Could breathing hydrogen protect the aging brain?
- App aims to empower older adults with memory challenges to master medication routines
- Could simple exercises slow cognitive decline? a new trial investigates.